论文信息 - The Efficacy of AR101, a Peanut-Derived Pharmaceutical for Oral Immunotherapy (OIT), Is Maintained and Tolerability Is Increased with Low-Dose Maintenance Therapy - 字舞流文

The Efficacy of AR101, a Peanut-Derived Pharmaceutical for Oral Immunotherapy (OIT), Is Maintained and Tolerability Is Increased with Low-Dose Maintenance Therapy

E. Crestani | A. Burks | B. Vickery | Julie Wang | M. Welch | J. Bird | S. Laubach | A. Cianferoni | Edwin H. Kim | J. Spergel | B. Davis | R. Rachid | J. Heimall | S. Leonard | A. MacGinnitie | S. R. Bennett | R. Elfont | A. Assa'ad | S. Jones